首页> 外文期刊>Journal of the Canadian Academy of Child and Adolescent Psychiatry >It’s More Complicated than Myth Busting: Parents Deciding About Stimulant Use for their Children
【24h】

It’s More Complicated than Myth Busting: Parents Deciding About Stimulant Use for their Children

机译:它比破坏神话还要复杂:父母决定为孩子使用兴奋剂

获取原文
       

摘要

Recently the Journal published a letter to the Editortitled “Stimulant use in attention deficit hyperactivitydisorder (ADHD) kids – triumph or tribulation?” (Naguy,2016). Although I appreciated the author’s intent to summarizepsychoeducational points with which to combat perceivedmyths that may serve as barriers to parents movingforward in considering stimulants for their child’s ADHD,I believe there are both technical and conceptual problemsin the letter.Concerns about stunting from stimulants were raised first.I found it curious that this was flagged as a leading concernas in my clinical experience few if any parents raised this asan issue in contrast to say risks of zombification. Of courseappetite suppression and its impact on weight are a frequentconcern for both parent and treating physician. The authorsuggested adding mirtazapine to address stimulant-inducedanorexia. While such an approach could be studied, it isclearly an off-label practice in Canada. Trying approvednon-stimulant ADHD medications, if stimulants are not tolerated,is an approach more consistent with best practicerecommendations (Pliszka et al., 2006).
机译:最近,《华尔街日报》向编辑发表了一封信,标题为“兴奋剂用于注意力缺陷多动障碍(ADHD)儿童–是胜利还是患难?” (纳吉,2016)。尽管我赞赏作者意图总结一些心理教育观点,以消除可能被父母误认为是他们的孩子多动症的兴奋剂的障碍的认知方法,但我相信这封信中存在技术和概念方面的问题。首先引起了人们对兴奋剂发育迟缓的担忧我感到奇怪的是,在我的临床经验中,这被标记为主要问题,很少有父母提出这个问题,而不是说僵尸化的风险。当然,食欲抑制及其对体重的影响是父母和主治医生经常关注的问题。作者建议添加米氮平来解决兴奋剂引起的厌氧症。虽然可以研究这种方法,但显然在加拿大这是不合常规的做法。如果不容许使用兴奋剂,则尝试批准的非兴奋性ADHD药物是一种与最佳实践建议更为一致的方法(Pliszka等,2006)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号